anaxirone has been researched along with Ovarian Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carnino, F; Dodion, P; George, M; Rotmensz, N; Scotto, V; ten Bokkel Huinink, WW; Vermorken, JB | 1 |
1 other study(ies) available for anaxirone and Ovarian Neoplasms
| Article | Year |
|---|---|
Phase II trial of anaxirone (1,2,4-triglycidylurazol, TGU) in patients with advanced ovarian carcinoma: an EORTC Gynecological Cancer Cooperative Group Study.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Middle Aged; Ovarian Neoplasms; Triazoles | 1987 |